Chronic obstructive pulmonary disease (COPD) is a global health crisis driven by oxidative stress and immune dysregulation. Emerging evidence positions ferroptosis—an iron-dependent cell death driven ...

Current therapies for chronic obstructive pulmonary disease (COPD) alleviate symptoms, but do not deal with disease progression. Respiratory mucus is primarily made up of mucins, of which mucin 5AC ...

Credit: Getty Images COPD stages are classified from Stage 1 (mild) to Stage 4 (very severe). In addition to, doctors also look at the severity of COPD symptoms. Based on FEV1, the COPD stage is mild, ...

This non-promotional AstraZeneca-sponsored symposium intended for healthcare professionals took place on 28 th September 2025 as part of the European Respiratory Society (ERS) Congress held in ...

– Global Phase 2 clinical trial, VENTURE, to evaluate the efficacy and safety of verekitug administered every 12 or 24 weeks in moderate-to-severe COPD – – Broadens global development program for ...

Phase 2 trial launched for verekitug in COPD, expanding treatment indications for severe respiratory conditions. Top data expected in 2026. Upstream Bio, Inc. has initiated a global Phase 2 clinical ...

In conclusion, COPD is a global disease, with increasing prevalence and health-related impact. The loss of FEV 1 may be slowing down, but what is really needed is an intervention that improves it in ...

Severe emphysema is a progressive, debilitating disease that quietly erodes patients’ quality of life, but emerging treatments like bronchoscopic lung volume reduction offer hope for restoring ...

Chronic obstructive pulmonary disease (COPD) is among the most leading causes of death around the world and there are insufficient treatment options that prevent exacerbations or alter the progression ...

Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disease that leads to death and disability worldwide, and it is caused by hereditary and environmental factors. It is ...